_id
6919f2573c536f8df2318638
Ticker
BRM.XETRA
Name
Bristol-Myers Squibb Company
Exchange
XETRA
Address
Route 206 & Province Line Road, Princeton, NJ, United States, 08543
Country
Germany
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Website
https://www.bms.com
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Last Close
46.135
Volume
635
Current Price
45.405
Change
-0.3034572450417266
Last Updated
2025-12-30T11:56:59.573Z
Image
https://logo.clearbit.com/www.bms.com
Ipo Date
-
Market Cap
93983817728
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
12222000000
Cost Of Revenue
3435000000
Gross Profit
8787000000
Operating Expenses
5148000000
Operating Income
3639000000
Interest Expense
480000000
Pretax Income
3114000000
Net Income
2201000000
Eps
1.0799999803725582
Dividends Per Share
1263000000
Shares Outstanding
2035753027
Income Tax Expense
919000000
EBITDA
4587000000
Operating Margin
29.774177712322043
Total Other Income Expense Net
-525000000
Cash
15726000000
Short Term Investments
776000000
Receivables
14616000000
Inventories
2758000000
Total Current Assets
35630000000
Property Plant Equipment
7349000000
Total Assets
96889000000
Payables
4288000000
Short Term Debt
4723000000
Long Term Debt
44469000000
Total Liabilities
78289000000
Equity
18552000000
Bs_currency_symbol
USD
Depreciation
1011000000
Change In Working Capital
3055000000
Cash From Operations
6311000000
Capital Expenditures
320000000
Cash From Investing
-1702000000
Cash From Financing
-1490000000
Net Change In Cash
3115000000
Cf_currency_symbol
USD
PE
18.2352
PB
4.987802394081501
ROE
11.863949978438983
ROA
2.2716717067985015
FCF
5991000000
Fcf Percent
0.49018163966617573
Piotroski FScore
4
Health Score
58
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
8.3
Garp Investing Score
5.5
Growth Investing Score
5
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
12222000000
Quarters > 0 > income Statement > cost Of Revenue
3435000000
Quarters > 0 > income Statement > gross Profit
8787000000
Quarters > 0 > income Statement > operating Expenses
5148000000
Quarters > 0 > income Statement > operating Income
3639000000
Quarters > 0 > income Statement > interest Expense
480000000
Quarters > 0 > income Statement > pretax Income
3114000000
Quarters > 0 > income Statement > net Income
2201000000
Quarters > 0 > income Statement > eps
1.0799999803725582
Quarters > 0 > income Statement > dividends Per Share
1263000000
Quarters > 0 > income Statement > shares Outstanding
2037963000
Quarters > 0 > income Statement > income Tax Expense
919000000
Quarters > 0 > income Statement > EBITDA
4587000000
Quarters > 0 > income Statement > operating Margin
29.774177712322043
Quarters > 0 > income Statement > total Other Income Expense Net
-525000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
15726000000
Quarters > 0 > balance Sheet > short Term Investments
776000000
Quarters > 0 > balance Sheet > receivables
14616000000
Quarters > 0 > balance Sheet > inventories
2758000000
Quarters > 0 > balance Sheet > total Current Assets
35630000000
Quarters > 0 > balance Sheet > property Plant Equipment
7349000000
Quarters > 0 > balance Sheet > total Assets
96889000000
Quarters > 0 > balance Sheet > payables
4288000000
Quarters > 0 > balance Sheet > short Term Debt
4723000000
Quarters > 0 > balance Sheet > long Term Debt
44469000000
Quarters > 0 > balance Sheet > total Liabilities
78289000000
Quarters > 0 > balance Sheet > equity
18552000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
2195000000
Quarters > 0 > cash Flow > depreciation
1011000000
Quarters > 0 > cash Flow > change In Working Capital
3055000000
Quarters > 0 > cash Flow > cash From Operations
6311000000
Quarters > 0 > cash Flow > capital Expenditures
320000000
Quarters > 0 > cash Flow > cash From Investing
-1702000000
Quarters > 0 > cash Flow > cash From Financing
-1490000000
Quarters > 0 > cash Flow > net Change In Cash
3115000000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
1.0799999803725582
Quarters > 0 > ratios > PB
4.987802394081501
Quarters > 0 > ratios > ROE
11.863949978438983
Quarters > 0 > ratios > ROA
2.2716717067985015
Quarters > 0 > ratios > FCF
5991000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.49018163966617573
Quarters > 0 > health Score
58
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
12269000000
Quarters > 1 > income Statement > cost Of Revenue
3372000000
Quarters > 1 > income Statement > gross Profit
8897000000
Quarters > 1 > income Statement > operating Expenses
5123000000
Quarters > 1 > income Statement > operating Income
3774000000
Quarters > 1 > income Statement > interest Expense
485000000
Quarters > 1 > income Statement > pretax Income
1773000000
Quarters > 1 > income Statement > net Income
1310000000
Quarters > 1 > income Statement > eps
0.6421568627450981
Quarters > 1 > income Statement > dividends Per Share
1262000000
Quarters > 1 > income Statement > shares Outstanding
2040000000
Quarters > 1 > income Statement > income Tax Expense
460000000
Quarters > 1 > income Statement > EBITDA
3269000000
Quarters > 1 > income Statement > operating Margin
30.760453174667862
Quarters > 1 > income Statement > total Other Income Expense Net
-2001000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
12599000000
Quarters > 1 > balance Sheet > short Term Investments
1004000000
Quarters > 1 > balance Sheet > receivables
15101000000
Quarters > 1 > balance Sheet > inventories
2737000000
Quarters > 1 > balance Sheet > total Current Assets
33222000000
Quarters > 1 > balance Sheet > property Plant Equipment
8649000000
Quarters > 1 > balance Sheet > total Assets
94676000000
Quarters > 1 > balance Sheet > payables
5427000000
Quarters > 1 > balance Sheet > short Term Debt
4909000000
Quarters > 1 > balance Sheet > long Term Debt
44470000000
Quarters > 1 > balance Sheet > total Liabilities
77187000000
Quarters > 1 > balance Sheet > equity
17435000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
1313000000
Quarters > 1 > cash Flow > depreciation
1011000000
Quarters > 1 > cash Flow > change In Working Capital
15000000
Quarters > 1 > cash Flow > cash From Operations
3917000000
Quarters > 1 > cash Flow > capital Expenditures
361000000
Quarters > 1 > cash Flow > cash From Investing
-473000000
Quarters > 1 > cash Flow > cash From Financing
-1836000000
Quarters > 1 > cash Flow > net Change In Cash
1736000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.6421568627450981
Quarters > 1 > ratios > PB
5.312658445655291
Quarters > 1 > ratios > ROE
7.513622024663034
Quarters > 1 > ratios > ROA
1.3836663990874138
Quarters > 1 > ratios > FCF
3556000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.28983617246719373
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
11201000000
Quarters > 2 > income Statement > cost Of Revenue
3033000000
Quarters > 2 > income Statement > gross Profit
8168000000
Quarters > 2 > income Statement > operating Expenses
4671000000
Quarters > 2 > income Statement > operating Income
3497000000
Quarters > 2 > income Statement > interest Expense
494000000
Quarters > 2 > income Statement > pretax Income
2971000000
Quarters > 2 > income Statement > net Income
2456000000
Quarters > 2 > income Statement > eps
1.203921568627451
Quarters > 2 > income Statement > dividends Per Share
1258000000
Quarters > 2 > income Statement > shares Outstanding
2040000000
Quarters > 2 > income Statement > income Tax Expense
509000000
Quarters > 2 > income Statement > EBITDA
4477000000
Quarters > 2 > income Statement > operating Margin
31.220426747611818
Quarters > 2 > income Statement > total Other Income Expense Net
-526000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10875000000
Quarters > 2 > balance Sheet > short Term Investments
907000000
Quarters > 2 > balance Sheet > receivables
11124000000
Quarters > 2 > balance Sheet > inventories
2666000000
Quarters > 2 > balance Sheet > total Current Assets
30783000000
Quarters > 2 > balance Sheet > property Plant Equipment
8428000000
Quarters > 2 > balance Sheet > total Assets
92427000000
Quarters > 2 > balance Sheet > payables
4002000000
Quarters > 2 > balance Sheet > short Term Debt
3726000000
Quarters > 2 > balance Sheet > long Term Debt
46157000000
Quarters > 2 > balance Sheet > total Liabilities
74979000000
Quarters > 2 > balance Sheet > equity
17389000000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
2462000000
Quarters > 2 > cash Flow > depreciation
1012000000
Quarters > 2 > cash Flow > change In Working Capital
-1871000000
Quarters > 2 > cash Flow > cash From Operations
1954000000
Quarters > 2 > cash Flow > capital Expenditures
260000000
Quarters > 2 > cash Flow > cash From Investing
-499000000
Quarters > 2 > cash Flow > cash From Financing
-993000000
Quarters > 2 > cash Flow > net Change In Cash
528000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
1.203921568627451
Quarters > 2 > ratios > PB
5.326712289378343
Quarters > 2 > ratios > ROE
14.123871412962217
Quarters > 2 > ratios > ROA
2.6572321940558497
Quarters > 2 > ratios > FCF
1694000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.1512364967413624
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
12342000000
Quarters > 3 > income Statement > cost Of Revenue
4812000000
Quarters > 3 > income Statement > gross Profit
7530000000
Quarters > 3 > income Statement > operating Expenses
7020000000
Quarters > 3 > income Statement > operating Income
510000000
Quarters > 3 > income Statement > interest Expense
496000000
Quarters > 3 > income Statement > pretax Income
175000000
Quarters > 3 > income Statement > net Income
72000000
Quarters > 3 > income Statement > eps
0.03545051698670606
Quarters > 3 > income Statement > dividends Per Share
1218000000
Quarters > 3 > income Statement > shares Outstanding
2031000000
Quarters > 3 > income Statement > income Tax Expense
99000000
Quarters > 3 > income Statement > EBITDA
2551000000
Quarters > 3 > income Statement > operating Margin
4.132231404958678
Quarters > 3 > income Statement > total Other Income Expense Net
-335000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
10346000000
Quarters > 3 > balance Sheet > short Term Investments
513000000
Quarters > 3 > balance Sheet > receivables
14424000000
Quarters > 3 > balance Sheet > inventories
2557000000
Quarters > 3 > balance Sheet > total Current Assets
29780000000
Quarters > 3 > balance Sheet > property Plant Equipment
8360000000
Quarters > 3 > balance Sheet > total Assets
92603000000
Quarters > 3 > balance Sheet > payables
3602000000
Quarters > 3 > balance Sheet > short Term Debt
2227000000
Quarters > 3 > balance Sheet > long Term Debt
47603000000
Quarters > 3 > balance Sheet > total Liabilities
76215000000
Quarters > 3 > balance Sheet > equity
16335000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
76000000
Quarters > 3 > cash Flow > depreciation
1880000000
Quarters > 3 > cash Flow > change In Working Capital
1276000000
Quarters > 3 > cash Flow > cash From Operations
4439000000
Quarters > 3 > cash Flow > capital Expenditures
378000000
Quarters > 3 > cash Flow > cash From Investing
-196000000
Quarters > 3 > cash Flow > cash From Financing
-1642000000
Quarters > 3 > cash Flow > net Change In Cash
2454000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.03545051698670606
Quarters > 3 > ratios > PB
5.645396694214876
Quarters > 3 > ratios > ROE
0.4407713498622589
Quarters > 3 > ratios > ROA
0.07775126075829077
Quarters > 3 > ratios > FCF
4061000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.32903905363798414
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
48300000000
Annuals > 0 > income Statement > cost Of Revenue
13968000000
Annuals > 0 > income Statement > gross Profit
34332000000
Annuals > 0 > income Statement > operating Expenses
28445000000
Annuals > 0 > income Statement > operating Income
5887000000
Annuals > 0 > income Statement > interest Expense
1947000000
Annuals > 0 > income Statement > pretax Income
-8379000000
Annuals > 0 > income Statement > net Income
-8948000000
Annuals > 0 > income Statement > eps
-4.405711472181191
Annuals > 0 > income Statement > dividends Per Share
4863000000
Annuals > 0 > income Statement > shares Outstanding
2031000000
Annuals > 0 > income Statement > income Tax Expense
554000000
Annuals > 0 > income Statement > EBITDA
3168000000
Annuals > 0 > income Statement > operating Margin
12.18840579710145
Annuals > 0 > income Statement > total Other Income Expense Net
-14266000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
10346000000
Annuals > 0 > balance Sheet > short Term Investments
513000000
Annuals > 0 > balance Sheet > receivables
14424000000
Annuals > 0 > balance Sheet > inventories
2557000000
Annuals > 0 > balance Sheet > total Current Assets
29780000000
Annuals > 0 > balance Sheet > property Plant Equipment
8360000000
Annuals > 0 > balance Sheet > total Assets
92603000000
Annuals > 0 > balance Sheet > payables
3602000000
Annuals > 0 > balance Sheet > short Term Debt
2227000000
Annuals > 0 > balance Sheet > long Term Debt
47603000000
Annuals > 0 > balance Sheet > total Liabilities
76215000000
Annuals > 0 > balance Sheet > equity
16335000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8933000000
Annuals > 0 > cash Flow > depreciation
9600000000
Annuals > 0 > cash Flow > change In Working Capital
810000000
Annuals > 0 > cash Flow > cash From Operations
15190000000
Annuals > 0 > cash Flow > capital Expenditures
1248000000
Annuals > 0 > cash Flow > cash From Investing
-21352000000
Annuals > 0 > cash Flow > cash From Financing
5127000000
Annuals > 0 > cash Flow > net Change In Cash
-1172000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.405711472181191
Annuals > 0 > ratios > PB
5.719375573921028
Annuals > 0 > ratios > ROE
-54.77808386899296
Annuals > 0 > ratios > ROA
-9.662753906460914
Annuals > 0 > ratios > FCF
13942000000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.28865424430641823
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
45006000000
Annuals > 1 > income Statement > cost Of Revenue
10693000000
Annuals > 1 > income Statement > gross Profit
34313000000
Annuals > 1 > income Statement > operating Expenses
34313000000
Annuals > 1 > income Statement > operating Income
8651000000
Annuals > 1 > income Statement > interest Expense
1166000000
Annuals > 1 > income Statement > pretax Income
8440000000
Annuals > 1 > income Statement > net Income
8025000000
Annuals > 1 > income Statement > eps
3.861886429258903
Annuals > 1 > income Statement > dividends Per Share
4744000000
Annuals > 1 > income Statement > shares Outstanding
2078000000
Annuals > 1 > income Statement > income Tax Expense
400000000
Annuals > 1 > income Statement > EBITDA
19366000000
Annuals > 1 > income Statement > operating Margin
19.221881526907524
Annuals > 1 > income Statement > total Other Income Expense Net
-211000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11464000000
Annuals > 1 > balance Sheet > short Term Investments
816000000
Annuals > 1 > balance Sheet > receivables
11337000000
Annuals > 1 > balance Sheet > inventories
2662000000
Annuals > 1 > balance Sheet > total Current Assets
31770000000
Annuals > 1 > balance Sheet > property Plant Equipment
8036000000
Annuals > 1 > balance Sheet > total Assets
95159000000
Annuals > 1 > balance Sheet > payables
3259000000
Annuals > 1 > balance Sheet > short Term Debt
3281000000
Annuals > 1 > balance Sheet > long Term Debt
36653000000
Annuals > 1 > balance Sheet > total Liabilities
65674000000
Annuals > 1 > balance Sheet > equity
29430000000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
8025000000
Annuals > 1 > cash Flow > depreciation
9760000000
Annuals > 1 > cash Flow > change In Working Capital
-1914000000
Annuals > 1 > cash Flow > cash From Operations
13860000000
Annuals > 1 > cash Flow > capital Expenditures
1209000000
Annuals > 1 > cash Flow > cash From Investing
-2295000000
Annuals > 1 > cash Flow > cash From Financing
-9416000000
Annuals > 1 > cash Flow > net Change In Cash
2194000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
3.861886429258903
Annuals > 1 > ratios > PB
3.2479782534828407
Annuals > 1 > ratios > ROE
27.268093781855253
Annuals > 1 > ratios > ROA
8.433253817295263
Annuals > 1 > ratios > FCF
12651000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.2810958538861485
Annuals > 1 > health Score
73
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
46159000000
Annuals > 2 > income Statement > cost Of Revenue
10137000000
Annuals > 2 > income Statement > gross Profit
36022000000
Annuals > 2 > income Statement > operating Expenses
26918000000
Annuals > 2 > income Statement > operating Income
10328000000
Annuals > 2 > income Statement > interest Expense
1232000000
Annuals > 2 > income Statement > pretax Income
7713000000
Annuals > 2 > income Statement > net Income
6327000000
Annuals > 2 > income Statement > eps
2.9482758620689653
Annuals > 2 > income Statement > dividends Per Share
4634000000
Annuals > 2 > income Statement > shares Outstanding
2146000000
Annuals > 2 > income Statement > income Tax Expense
1368000000
Annuals > 2 > income Statement > EBITDA
19923000000
Annuals > 2 > income Statement > operating Margin
22.37483481011287
Annuals > 2 > income Statement > total Other Income Expense Net
-1391000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9123000000
Annuals > 2 > balance Sheet > short Term Investments
130000000
Annuals > 2 > balance Sheet > receivables
10390000000
Annuals > 2 > balance Sheet > inventories
2339000000
Annuals > 2 > balance Sheet > total Current Assets
27273000000
Annuals > 2 > balance Sheet > property Plant Equipment
7475000000
Annuals > 2 > balance Sheet > total Assets
96820000000
Annuals > 2 > balance Sheet > payables
3040000000
Annuals > 2 > balance Sheet > short Term Debt
4400000000
Annuals > 2 > balance Sheet > long Term Debt
35056000000
Annuals > 2 > balance Sheet > total Liabilities
65702000000
Annuals > 2 > balance Sheet > equity
31061000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
6345000000
Annuals > 2 > cash Flow > depreciation
10276000000
Annuals > 2 > cash Flow > change In Working Capital
-2229000000
Annuals > 2 > cash Flow > cash From Operations
13066000000
Annuals > 2 > cash Flow > capital Expenditures
1118000000
Annuals > 2 > cash Flow > cash From Investing
-1062000000
Annuals > 2 > cash Flow > cash From Financing
-16962000000
Annuals > 2 > cash Flow > net Change In Cash
-4991000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
2.9482758620689653
Annuals > 2 > ratios > PB
3.1781333505038476
Annuals > 2 > ratios > ROE
20.369595312449697
Annuals > 2 > ratios > ROA
6.5348068580871725
Annuals > 2 > ratios > FCF
11948000000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.2588444290387573
Annuals > 2 > health Score
71
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
46385000000
Annuals > 3 > income Statement > cost Of Revenue
9940000000
Annuals > 3 > income Statement > gross Profit
36445000000
Annuals > 3 > income Statement > operating Expenses
27908000000
Annuals > 3 > income Statement > operating Income
10159000000
Annuals > 3 > income Statement > interest Expense
1334000000
Annuals > 3 > income Statement > pretax Income
8098000000
Annuals > 3 > income Statement > net Income
6994000000
Annuals > 3 > income Statement > eps
3.1153674832962137
Annuals > 3 > income Statement > dividends Per Share
4396000000
Annuals > 3 > income Statement > shares Outstanding
2245000000
Annuals > 3 > income Statement > income Tax Expense
1084000000
Annuals > 3 > income Statement > EBITDA
20118000000
Annuals > 3 > income Statement > operating Margin
21.901476770507706
Annuals > 3 > income Statement > total Other Income Expense Net
-2061000000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
13979000000
Annuals > 3 > balance Sheet > short Term Investments
3242000000
Annuals > 3 > balance Sheet > receivables
9730000000
Annuals > 3 > balance Sheet > inventories
2095000000
Annuals > 3 > balance Sheet > total Current Assets
33262000000
Annuals > 3 > balance Sheet > property Plant Equipment
6968000000
Annuals > 3 > balance Sheet > total Assets
109314000000
Annuals > 3 > balance Sheet > payables
2949000000
Annuals > 3 > balance Sheet > short Term Debt
5117000000
Annuals > 3 > balance Sheet > long Term Debt
39605000000
Annuals > 3 > balance Sheet > total Liabilities
73308000000
Annuals > 3 > balance Sheet > equity
35946000000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
7014000000
Annuals > 3 > cash Flow > depreciation
10686000000
Annuals > 3 > cash Flow > change In Working Capital
-1253000000
Annuals > 3 > cash Flow > cash From Operations
16207000000
Annuals > 3 > cash Flow > capital Expenditures
973000000
Annuals > 3 > cash Flow > cash From Investing
-538000000
Annuals > 3 > cash Flow > cash From Financing
-16224000000
Annuals > 3 > cash Flow > net Change In Cash
-657000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
3.1153674832962137
Annuals > 3 > ratios > PB
2.8729204918488844
Annuals > 3 > ratios > ROE
19.456963222611694
Annuals > 3 > ratios > ROA
6.398082587774667
Annuals > 3 > ratios > FCF
15234000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.32842513743667134
Annuals > 3 > health Score
75
Valuation > metrics > PE
18.2352
Valuation > metrics > PB
4.987802394081501
Valuation > final Score
60.12197605918499
Valuation > verdict
33.1% Overvalued
Profitability > metrics > ROE
11.863949978438983
Profitability > metrics > ROA
6.177378613527925
Profitability > metrics > Net Margin
0.18008509245622648
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
4.219976282880552
Risk > metrics > Interest Coverage
7.58125
Risk > final Score
36
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.9540561535900567
Liquidity > metrics > Quick Ratio
3.6479857951392742
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
46.87341554344709
Prev Valuations > 1
46.73287710621657
Prev Valuations > 2
43.54603305785125
Prev Profitabilities > 0
43
Prev Profitabilities > 1
82
Prev Profitabilities > 2
2
Prev Risks > 0
37
Prev Risks > 1
34
Prev Risks > 2
10
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:46.404Z
Earnings History > 0 > period
2026-09-30
Earnings History > 0 > report Date
2026-10-29
Earnings History > 0 > date
2026-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2026-06-30
Earnings History > 1 > report Date
2026-07-30
Earnings History > 1 > date
2026-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2026-03-31
Earnings History > 2 > report Date
2026-04-30
Earnings History > 2 > date
2026-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-12-31
Earnings History > 3 > report Date
2026-02-05
Earnings History > 3 > date
2025-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-
Earnings History > 3 > eps Estimate
1.68
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-09-30
Earnings History > 4 > report Date
2025-10-30
Earnings History > 4 > date
2025-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.9238
Earnings History > 4 > eps Estimate
1.52
Earnings History > 4 > eps Difference
-0.5962
Earnings History > 4 > surprise Percent
-39.2237
Earnings History > 5 > period
2025-06-30
Earnings History > 5 > report Date
2025-07-31
Earnings History > 5 > date
2025-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0.5667
Earnings History > 5 > eps Estimate
1.16
Earnings History > 5 > eps Difference
-0.5933
Earnings History > 5 > surprise Percent
-51.1466
Earnings History > 6 > period
2025-03-31
Earnings History > 6 > report Date
2025-04-24
Earnings History > 6 > date
2025-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
1.1439
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-12-31
Earnings History > 7 > report Date
2025-02-06
Earnings History > 7 > date
2024-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0.0331
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-09-30
Earnings History > 8 > report Date
2024-09-30
Earnings History > 8 > date
2024-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0.5428
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2024-06-30
Earnings History > 9 > report Date
2024-06-30
Earnings History > 9 > date
2024-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.7691
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2024-03-31
Earnings History > 10 > report Date
2024-03-31
Earnings History > 10 > date
2024-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-5.4248
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-12-31
Earnings History > 11 > report Date
2023-12-31
Earnings History > 11 > date
2023-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0.8059
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-09-30
Earnings History > 12 > report Date
2023-09-30
Earnings History > 12 > date
2023-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.8587
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2023-06-30
Earnings History > 13 > report Date
2023-06-30
Earnings History > 13 > date
2023-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0.9062
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2023-03-31
Earnings History > 14 > report Date
2023-03-31
Earnings History > 14 > date
2023-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0.9977
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-12-31
Earnings History > 15 > report Date
2022-12-31
Earnings History > 15 > date
2022-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0.9333
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-09-30
Earnings History > 16 > report Date
2022-09-30
Earnings History > 16 > date
2022-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0.7427
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2022-06-30
Earnings History > 17 > report Date
2022-06-30
Earnings History > 17 > date
2022-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
0.6213
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2022-03-31
Earnings History > 18 > report Date
2022-03-31
Earnings History > 18 > date
2022-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0.5264
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-12-31
Earnings History > 19 > report Date
2021-12-31
Earnings History > 19 > date
2021-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0.9352
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-09-30
Earnings History > 20 > report Date
2021-09-30
Earnings History > 20 > date
2021-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0.5847
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2021-06-30
Earnings History > 21 > report Date
2021-06-30
Earnings History > 21 > date
2021-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
0.3886
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2021-03-31
Earnings History > 22 > report Date
2021-03-31
Earnings History > 22 > date
2021-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0.7408
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-12-31
Earnings History > 23 > report Date
2020-12-31
Earnings History > 23 > date
2020-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-3.7347
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-09-30
Earnings History > 24 > report Date
2020-09-30
Earnings History > 24 > date
2020-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0.6994
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2020-06-30
Earnings History > 25 > report Date
2020-06-30
Earnings History > 25 > date
2020-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.0341
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2020-03-31
Earnings History > 26 > report Date
2020-03-31
Earnings History > 26 > date
2020-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-0.3115
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-12-31
Earnings History > 27 > report Date
2019-12-31
Earnings History > 27 > date
2019-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.4973
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-09-30
Earnings History > 28 > report Date
2019-09-30
Earnings History > 28 > date
2019-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
0.7447
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2019-06-30
Earnings History > 29 > report Date
2019-06-30
Earnings History > 29 > date
2019-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
0.7785
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2019-03-31
Earnings History > 30 > report Date
2019-03-31
Earnings History > 30 > date
2019-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
0.92
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bristol-Myers Squibb Company
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
1.68
Date
2025-09-30
EPS Actual
0.9238
EPS Estimate
1.52
EPS Difference
-0.5962
Surprise Percent
-39.2237%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.